Market Cap (In SEK)
1.38 Billion
Revenue (In SEK)
112.15 Million
Net Income (In SEK)
-130.49 Million
Avg. Volume
370.32 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.91-10.94
- PE
- -28.28
- EPS
- -0.5
- Beta Value
- 0.843
- ISIN
- SE0012570448
- CUSIP
- -
- CIK
- -
- Shares
- 97658900.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Morten Henneveld
- Employee Count
- -
- Website
- https://www.ossdsign.com
- Ipo Date
- 2019-05-24
- Details
- OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
More Stocks
-
BDRXFBombardier Inc.
BDRXF
-
0HQ3
-
KWS
-
NVONovo Nordisk A/S
NVO
-
EXELExelixis, Inc.
EXEL
-
TISITeam, Inc.
TISI
-
JDEPFJDE Peet's N.V.
JDEPF
-
NGS